Levetiracetam Tablet, Film Coated
Product Images NDC 16714-034

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 16714-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levestructure (Levestructure)

Chemical structure of the active ingredient levetiracetam, showing a pyrrolidone ring attached to an ethyl group and a carbonyl-containing side chain.*

FDA Label Image

Levestructure1 (Levestructure1)

Bar graph showing the percentage of patients by treatment group receiving placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The chart compares patient response rates across these three groups with values indicated above each bar.*

FDA Label Image

Levetiracetamstructure2 (Levetiracetamstructure2)

A bar graph showing the percentage of patients in three groups: Placebo (6.3%, N=111), Levetiracetam 1000 mg/day (20.8%, N=106), and Levetiracetam 2000 mg/day (35.2%, N=105). The vertical axis represents the percentage of patients from 0% to 45%, with an asterisk marking the Levetiracetam bars indicating statistical significance or emphasis.*

FDA Label Image

Levetiracetamstructure3 (Levetiracetamstructure3)

This bar chart compares the percentage of patients responding to treatment between placebo and Levetiracetam 3000 mg/day groups. The vertical axis represents percent of patients from 0% to 45%. The placebo group (N=104) shows 14.4% responders, while the Levetiracetam 3000 mg/day group (N=180) shows 39.4% responders, marked with an asterisk.*

FDA Label Image

Levetiracetamstructure4 (Levetiracetamstructure4)

Bar chart comparing the percentage of patients between two groups: Placebo (N=97) with 19.6%, and Levetiracetam (N=101) with 44.6%. The y-axis represents the percentage of patients, ranging from 0% to 45%. An asterisk is present above the Levetiracetam bar.*

FDA Label Image

Levetiracetamstructure5 (Levetiracetamstructure5)

A bar chart comparing the percentage of patients for Placebo (N=51) and Levetiracetam (N=58). The y-axis shows the percentage of patients from 0% to 45%. The Placebo group shows 19.6%, and the Levetiracetam group shows 43.1% with a symbol above the bar.*

FDA Label Image

Levetiracetamstructure6 (Levetiracetamstructure6)

A bar chart comparing the percentage of patients for placebo (45.2%) and Levetiracetam (72.2%). The x-axis shows treatment groups (Placebo N=84 and Levetiracetam N=79), and the y-axis shows the percentage of patients from 0% to 100%. Levetiracetam group has a higher patient percentage with an asterisk indicating statistical significance.*

FDA Label Image

Levetiracetam250mg500shetero (Levetiracetam250mg500shetero)

Label for Levetiracetam Tablets USP 250 mg, film-coated oral tablets, bottled as 500 tablets. Label shows NDC 16714-034-02. Manufactured for NorthStar Rx LLC, Memphis, TN, and by Hetero Labs Limited, Hyderabad, India. Includes pharmacist dispensing instructions and storage conditions at controlled room temperature.*

FDA Label Image

Levetiracetam500mg500shetero (Levetiracetam500mg500shetero)

Label for Levetiracetam Tablets, USP 500 mg, a film-coated oral tablet. The label indicates a package count of 500 tablets. It is manufactured by Hetero Labs Limited, India, for NorthStar Rx LLC. The label highlights pharmacist instructions and storage conditions (20° to 25°C). The design includes a blue and white color scheme with a barcode and batch coding area.*

FDA Label Image

Levetiracetam750mg500shetero (Levetiracetam750mg500shetero)

Label for Levetiracetam Tablets, USP 750 mg, film-coated oral tablets. The label states pharmacist dispensing instructions and storage conditions, lists the manufacturer as Hetero Labs Limited in India, the labeler as Northstar Rx LLC in Memphis, TN, and includes the NDC 16714-537-02. The package contains 500 tablets.*

FDA Label Image

Levetiracetam1000mg60shetero (Levetiracetam1000mg60shetero)

Label for Levetiracetam Tablets USP 1000 mg, film-coated oral tablets, containing 60 tablets per container. Label shows manufacturer as NorthStar Rx LLC and Hetero Labs Limited, India. Instructions for pharmacist storage and dispensing are included along with a barcode and batch coding area. Issued date is 10/2021.*

FDA Label Image

Levetiracetam250mg120sannora (Levetiracetam250mg120sannora)

Label for Levetiracetam Tablets, USP 250 mg film-coated tablets by NorthStar RxLLC. The label indicates a package of 120 tablets. It includes storage instructions, pharmacist dispensing guidance, and manufacturer information for Annora Pharma Pvt. Ltd., India. The label shows NDC 16714-034-01 and features a barcode.*

FDA Label Image

Levetiracetam500mg120sannora (Levetiracetam500mg120sannora)

Label for Levetiracetam Tablets USP 500 mg film-coated oral tablets, containing 120 tablets per container. The label includes storage instructions (20° to 25°C), pharmacist dispensing guidance, manufacturer details (Annora Pharma Pvt. Ltd., India), and labeler information (Northstar Rx LLC, Memphis, TN). Barcode and issuance date 04/2022 are also visible.*

FDA Label Image

Levetiracetam750mg120sannora (Levetiracetam750mg120sannora)

Label for Levetiracetam Tablets, USP 750 mg, film-coated oral tablets. The label specifies 120 tablets per container, manufactured for NorthStar Rx LLC, Memphis, TN, and by Annora Pharma Pvt. Ltd., Telangana, India. It includes storage instructions and pharmacist dispensing notes, with an NDC of 16714-537-01.*

FDA Label Image

Levetiracetam1000mg60sannora (Levetiracetam1000mg60sannora)

Label for Levetiracetam Tablets USP 1000 mg film-coated oral tablets. The package contains 60 tablets. It is labeled for prescription use only by NorthStar Rx LLC. The label notes pharmacist dispensing instructions, storage conditions, manufacturer information including Annora Pharma Pvt. Ltd. in India, and a medication guide availability link.*

FDA Label Image

Levetiracetam250mg120svemagal (Levetiracetam250mg120svemagal)

Levetiracetam Tablets, USP 250 mg film-coated oral tablets label from NorthStar Rx LLC. The label indicates 120 tablets per container with prescription only use. Manufactured by Hetero Labs Limited, India, it includes storage instructions, pharmacist guidance, and a barcode.*

FDA Label Image

Levetiracetam500mg120svemagal (Levetiracetam500mg120svemagal)

Levetiracetam Tablets USP 500 mg film-coated oral tablets label showing a quantity of 120 tablets. Labeled for NorthStar Rx LLC, this prescription drug label includes storage instructions, pharmacist dispensing guidance, batch coding area, manufacturer information (Hetero Labs Limited, India), and a barcode.*

FDA Label Image

Levetiracetam750mg120svemagal (Levetiracetam750mg120svemagal)

Levetiracetam Tablets USP 750 mg film-coated tablets label for a 120-tablet bottle. The label displays the product name, strength, pharmacist dispensing instructions, storage temperature, medication guide availability, manufacturer (Hetero Labs Limited, India), and the labeler (NorthStar Rx LLC). It includes barcode and batch coding area.*

FDA Label Image

Levetiracetam1000mg60svemagal (Levetiracetam1000mg60svemagal)

Levetiracetam Tablets, USP 1000 mg film-coated tablets packaging label. The label indicates 60 tablets per container, manufactured for Northstar Rx LLC, Memphis, TN, with manufacturing and expiration details. It includes pharmacist dispensing instructions and storage conditions. The product is made by Hetero Labs Limited in India, with a barcode and NDC 16714-310-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.